Baird Initiates Coverage On Merit Medical Systems with Outperform Rating, Announces Price Target of $96
Portfolio Pulse from Benzinga Newsdesk
Baird analyst David Rescott has initiated coverage on Merit Medical Systems (NASDAQ:MMSI) with an Outperform rating and a price target of $96.
June 28, 2024 | 9:18 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst David Rescott has initiated coverage on Merit Medical Systems with an Outperform rating and a price target of $96.
The initiation of coverage with an Outperform rating and a price target of $96 by a reputable analyst is likely to positively impact the stock price of Merit Medical Systems in the short term. This rating suggests strong confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100